Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells

Publisher： Bentham Science Publishers

E-ISSN： 2212-4063|9|1|62-77

ISSN： 1871-529X

Source： Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol.9, Iss.1, 2009-03, pp. : 62-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunomodulatory Effects of Histone Deacetylase Inhibitors

By  

Current Molecular Medicine, Vol. 13, Iss. 4, 2013-05 ,pp. : 640-647

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Development of Suberoylanilide Hydroxamic Acid (SAHA) for the Treatment of Cancers

By Richon V.M.   Zhou X.   Rifkind R.A.   Marks P.A.  

Blood Cells, Molecules, and Diseases, Vol. 27, Iss. 1, 2001-01 ,pp. : 260-264

Academic Press

Access to resources Recommend Favorite

Pharmacological Induction of Fetal Hemoglobin Synthesis using Histone Deacetylase Inhibitors

By Cao Hua  

Hematology, Vol. 9, Iss. 3, 2004-06 ,pp. : 223-233

Maney Publishing

Access to resources Recommend Favorite

The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 7, Iss. 4, 2007-12 ,pp. : 250-273

Bentham Science Publishers

Access to resources Recommend Favorite

The effect of proteasome inhibitors on mammalian erythroid terminal differentiation

By Chen C.-Y.   Pajak L.   Tamburlin J.   Bofinger D.   Koury S.T.  

Experimental Hematology, Vol. 30, Iss. 7, 2002-07 ,pp. : 634-639

Elsevier

Access to resources Recommend Favorite